Alpha DNA Investment Management’s American Express AXP Stock Holding History
Bought
Maintained
Sold
Other funds holding AXP
Alpha DNA Investment Management's AXP Position: Q3 2024 in Review
Alpha DNA Investment Management sold out of American Express (AXP) in Q3 2024, closing a stake of 7,956 shares — an estimated $1.84M sold.
Alpha DNA Investment Management first reported a position in AXP in Q1 2024 and held it in 2 quarters. The position peaked at $1.91M in Q1 2024. 2,450 funds tracked by Wall St. Rank hold AXP as of Q3 2024.
- Alpha DNA Investment Management reported no remaining American Express position as of Q3 2024 after selling out during the quarter.
- Alpha DNA Investment Management sold 7,956 American Express shares in Q3 2024, an estimated $1.84M.
- Alpha DNA Investment Management first reported a position in American Express in Q1 2024 and held it in 2 quarters.
- Alpha DNA Investment Management's American Express position peaked at $1.91M in Q1 2024.
- 2,450 funds tracked by Wall St. Rank held American Express as of Q3 2024.
Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.